How public bodies contract for research they cannot specify in advance
Research procurement has a structural problem: the buyer is purchasing an answer to a question, and if the answer were known the contract would be unnecessary. Public bodies deal with this by buying in phases. A feasibility or concept phase is awarded to several suppliers in parallel, each paid a modest fixed sum; a subset is then funded to prototype; a smaller subset again reaches demonstration. Each phase is a competition among the survivors of the last, so a bidder should read the notice for the phase structure and the progression criteria before pricing anything.
Intellectual property is the term that decides whether the contract is worth winning. Arrangements range from full assignment of results to the buyer, through a license to the buyer with the supplier retaining ownership and the right to commercialise elsewhere, to background and foreground IP splits that must be catalogued before work starts. Development-focused schemes often deliberately leave ownership with the supplier so that a market can form around the result, while procurement of research for internal use tends toward assignment. The two produce very different bid economics.
Evaluation weights the proposal's scientific and technical merit, the team's record, and the credibility of the risk assessment, and it rewards candour about what might fail. Deliverables are reports, data and demonstrations rather than products, so acceptance criteria are written around defined technical readiness levels or measurable milestones. Where human participants, animals, personal data or dual-use technology are involved, ethical approval and export control clearance are conditions precedent with their own timetables, and they are a common cause of a project starting months after award.
This section describes how this category is bought generally, across the public buyers that publish it. The figures elsewhere on this page are measured for this market alone.
Who buys research & development in Uruguay?
GlobalGov holds 151 research & development records from 59 distinct buying organizations in Uruguay. The most frequent publishers are Universidad Tecnológica Del Uruguay (16 records); Administración De Servicios De Salud Del Estado | Centro Departamental De Maldonado (10 records); Banco de Previsión Social (10 records); Administración de Servicios de Salud del Estado | Hospital Maciel (9 records); Administración de Servicios de Salud del Estado | Centro Hospitalario Pereira Rossell (8 records); Administración De Las Obras Sanitarias Del Estado (6 records). Between them the 6 largest account for 39% of everything published, so buying here is spread across many separate authorities.
| Buying organization | Records | Share |
|---|---|---|
| Universidad Tecnológica Del Uruguay | 16 | 11% |
| Administración De Servicios De Salud Del Estado | Centro Departamental De Maldonado | 10 | 6.6% |
| Banco de Previsión Social | 10 | 6.6% |
| Administración de Servicios de Salud del Estado | Hospital Maciel | 9 | 6.0% |
| Administración de Servicios de Salud del Estado | Centro Hospitalario Pereira Rossell | 8 | 5.3% |
| Administración De Las Obras Sanitarias Del Estado | 6 | 4.0% |
How long do bidders get to respond to research & development tenders in Uruguay?
Across the 128 Uruguay research & development notices that publish both a publication date and a closing date, the median response window is 11 days. A quarter of them allowed 4 days or fewer and a quarter stayed open for more than 17. 77 of them (60%) closed within a fortnight of being published, so on this market a bidder who reviews notices once a week can lose most of the response window before reading one.
How often are research & development tenders published in Uruguay?
Uruguay publishes about 13 notices a month in this category, 151 in the last twelve months. Over the last three years there were 151, spread across 6 separate months of activity since 25 June 2026. October is historically the busiest month. The most recent was published 19 November 2026.
How does Uruguay compare with other research & development markets?
Among the 49 countries where GlobalGov holds a comparable research & development market, Uruguay ranks 41st by number of records. The largest is Australia (13,466 records against 151 here). Within Uruguay itself, research & development is the 5th largest of the 15 procurement categories tracked here.
Where do the Uruguay research & development records on this page come from?
These 151 records are collected from 1 official source: ARCE (151). GlobalGov is an independent aggregator and is not affiliated with any of them; each record links back to the notice on its issuing portal. The set is rebuilt nightly, and the counts on this page were taken on 2026-11-22.
Open Research & Development tenders in Uruguay
Showing 7 of the 7 notices open in this category today. Openness uses the same definition as the Uruguay market page: active, not marked awarded, cancelled, closed or expired, and either closing in the future or published within the last 90 days with no stated closing date.
Price competition 11351/2026 — acquisition of laboratory inputs.
Price competition 13/2026 — hiring a company or research institutes to develop economic models for predicting electrical demand
Abbreviated invitation to tender 21/2026 — electrical laboratory conditioning.
Direct Purchase 18335/2026 — SAMPLE PROCESSING DE PARA ANATOMOPATHOLOGICAL STUDY and stamps. Attached is the patient spreadsheet DE September and October. Corresponds to Invoice No. 1729
Direct Purchase 16251/2026 — INSUMS OF PAY SIIF LABORATORY
Direct Purchase 14661/2026 — Sample processing for anatomopathological study.
Other procurement categories in Uruguay
Research & Development procurement in other markets
Never Miss a Uruguay Government Contract
Finding Uruguay tenders usually means a local portal, a local registration and someone who reads the language. Get an alert you can read when a new research & development opportunity is published there.
Start Free Trial